Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Grimaldi

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
Trials|December 15, 2020
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
Annals of Intensive Care|March 6, 2026
Health-related quality of life trajectories one year after COVID-19-induced ARDS: A secondary analysis of the CONFIDENT trialAnne-Françoise Rousseau, Nadia Dardenne, Axelle Bertrand, et al.
Chest|June 23, 2020
Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM StudyAlexandre Demoule, Massimo Antonelli, Peter Schellongowski, et al.
Intensive Care Medicine|February 22, 2017
Targeted temperature management after intraoperative cardiac arrest: a multicenter retrospective studyAnne-Laure Constant, Nicolas Mongardon, Quentin Morelot, et al.
Critical Care (London, England)|June 18, 2022
Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trialEleni Karakike, Brendon P Scicluna, Maria Roumpoutsou, et al.
The Lancet. Respiratory Medicine|February 22, 2017
Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trialPierre Asfar, Frédérique Schortgen, Julie Boisramé-Helms, et al.
Journal of Thoracic Disease|October 18, 2016
AME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospitalZhongheng Zhang, Nathan J Smischney, Haibo Zhang, et al.
British Journal of Anaesthesia|November 9, 2021
Learning from terrorist mass casualty incidents: a global surveyRosel Tallach, Sharon Einav, Karim Brohi, et al.
The New England Journal of Medicine|October 27, 2023
Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated PatientsBenoît Misset, Michael Piagnerelli, Eric Hoste, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
Trials|December 15, 2020
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
Annals of Intensive Care|March 6, 2026
Health-related quality of life trajectories one year after COVID-19-induced ARDS: A secondary analysis of the CONFIDENT trialAnne-Françoise Rousseau, Nadia Dardenne, Axelle Bertrand, et al.
Chest|June 23, 2020
Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM StudyAlexandre Demoule, Massimo Antonelli, Peter Schellongowski, et al.
Intensive Care Medicine|February 22, 2017
Targeted temperature management after intraoperative cardiac arrest: a multicenter retrospective studyAnne-Laure Constant, Nicolas Mongardon, Quentin Morelot, et al.
Critical Care (London, England)|June 18, 2022
Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trialEleni Karakike, Brendon P Scicluna, Maria Roumpoutsou, et al.
The Lancet. Respiratory Medicine|February 22, 2017
Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trialPierre Asfar, Frédérique Schortgen, Julie Boisramé-Helms, et al.
Journal of Thoracic Disease|October 18, 2016
AME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospitalZhongheng Zhang, Nathan J Smischney, Haibo Zhang, et al.
British Journal of Anaesthesia|November 9, 2021
Learning from terrorist mass casualty incidents: a global surveyRosel Tallach, Sharon Einav, Karim Brohi, et al.
The New England Journal of Medicine|October 27, 2023
Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated PatientsBenoît Misset, Michael Piagnerelli, Eric Hoste, et al.
Pageof 13